Ambalal Sarabhai — 360° view

Ambalal Sarabhai, a company in the Pharmaceuticals industry, reported revenue of ₹58 crore and net profit of ₹0.67 crore for the September 2026 quarter.

Ambalal Sarabhai (NSE: AMBALALSA-BE) closed at ₹38.90 on 20 Nov 2026, up 30.1% over the past year. Its market capitalisation is ₹298 crore and it trades at 19.3 times earnings.

Share price
₹38.90 (20 Nov 2026)
Market cap
₹298 Cr (20 Nov 2026)
P/E
19.27 (20 Nov 2026)
Revenue
₹58 Cr (September 2026 quarter)
Net profit
₹1 Cr (September 2026 quarter)
ROCE
11.7% (FY26)
ROE
12.4% (FY26)
Book value
₹21.3 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹49.98 / ₹23.12 (20 Nov 2026)
1-year return
30.1% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: AMBALALSA-BE

Incorporated in 1977, Ambalal Sarabhai Enterprises Ltd is in the business of manufacturing Pharmaceuticals and Electronics

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.